OTC Derivatives Clearing Summit: Buy side bemoans ‘lowest common denominator’ treatment

speed-limit-40mph-sign-rainbow

Buy-side firms have hit out at a loss of flexibility as the over-the-counter market migrates towards central clearing – with big, real-money funds arguing they are being forced to margin trades on the same terms as hedge funds while also losing some of the customisation available in OTC documentation.

“Highly creditworthy buy-side institutions like ourselves are, in essence, being subjected to the lowest common denominator in terms of margin requirements. The requirements from the clearing house

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

If you already have an account, please sign in here.

Register

Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: